Delivery Order 75N93020D00006-75N93020F00002
- Bioqual, Inc., a biomedical research services company based in Rockville, Maryland, was awarded a delivery order valued at $2.77 million for core administrative and technical support services under the Simian Vaccine Evaluation Units (SVEUS) program. This cost-plus-fixed-fee delivery order, issued by the National Institute of Allergy and Infectious Diseases (NIAID), commenced on April 1, 2020, and will conclude on March 31, 2027. The work is being performed at Bioqual's facility in Rockville,...
- Bioqual, Inc. was awarded a delivery order valued at $1.41 million by the National Institute of Allergy and Infectious Diseases (NIAID) on May 1, 2013, for Simian Vaccine Evaluation Units. This cost-plus-fixed-fee contract, which concluded on April 30, 2015, was performed in Potomac, Maryland, and represents work under the broader Simian Vaccine Evaluation Units 2013-2020 indefinite delivery vehicle. No set-aside designation was applied to this award, allowing Bioqual to compete in the open...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $3.14 million to Bioqual, Inc. for the conduct of Study P172 under the Simian Vaccine Evaluation Units master IDIQ contract (2013-2020). This cost-plus-fixed-fee delivery order, awarded May 1, 2013, with an ultimate completion date of April 22, 2023, supports NIAID's research infrastructure for evaluating vaccine candidates and countermeasures against infectious diseases using non-human primate...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bioqual, Inc. as the prime contractor. The contract, valued at $544,999.84, is for the housing and maintenance of non-human primates in support of biomedical research. This award falls under Bioqual's existing Simian Vaccine Evaluation Units (SVEU) indefinite-delivery/indefinite-quantity (IDIQ) contract with NIAID, which...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $782,160.63 to Bioqual, Inc. for the conduct of Study P218. This unilateral modification (Amendment 2) updates Federal Procurement Data System (FPDS) reporting processes to ensure compliance with a Presidential Memorandum regarding radical transparency about wasteful spending. The contract utilizes a cost-plus-fixed-fee pricing structure with a completion date of June 4, 2024. Bioqual, Inc., a...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit biomedical research services company located in Rockville, Maryland. The contract is for the housing and maintenance of non-human primates for NIAID's Vaccine Research Center (VRC), with a total ceiling value of $2,438,569.73 and a period of performance through July 2, 2024. The contract was awarded on August 8, 2019 and is a firm...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc., a for-profit organization, to provide housing and maintenance of non-human primates for the NIAID Vaccine Research Center (NIAID-VRC). The contract has a potential value of $7,029,016.11 and a completion date of September 27, 2019. Bioqual, Inc. is an accredited company that supports...
- This is a $399,995.93 firm-fixed-price delivery order federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a small business. The contract is for the housing and maintenance of laboratory animals, specifically non-human primates, in support of NIAID's Vaccine Research Center (VRC). The contract is set aside for small businesses and is issued under NIAID's Simian Vaccine Evaluation Units (SVEU)...
- This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc., a for-profit organization, for the housing and maintenance of non-human primates for the NIAID Vaccine Research Center (NIAID-VRC). The contract has a potential value of $5,396,898.20 and a completion date of September 27, 2019. Bioqual, Inc. is an experienced provider of...
- This firm-fixed-price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc., a for-profit organization, for the housing and maintenance of non-human primates for the NIAID Vaccine Research Center (NIAID-VRC). The $244,986.00 award has a completion date of December 19, 2019 and was made on December 20, 2018. Bioqual, a fully accredited company that provides...
- Simian Vaccine Evaluation UnitsMaster IDIQ
- 75N93020D00006Indefinite Delivery Contract
- 75N93020D00006-75N93020F00002Delivery Order
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.41 million to Bioqual, Inc. for the maintenance of non-human primates in an ABSL2/3 (Animal Biosafety Level 2/3) facility under the Simian Vaccine Evaluation Units (SVEU) program. The contract, awarded April 1, 2020, with an ultimate completion date of March 31, 2027, is structured as a cost-plus-fixed-fee delivery order with no set-aside designation. Bioqual, a for-profit biomedical research services company based in Rockville, Maryland, will perform the work at its facility in Rockville. This delivery order falls under NIAID's broader SVEU master indefinite delivery contract, which supports the agency's critical mission of developing and evaluating animal models for assessing countermeasures against infectious diseases. Bioqual brings substantial expertise to this engagement, holding two significant NIAID indefinite delivery contracts totaling over $691 million and demonstrating a track record of specialized animal research support since 1999. The company's core competencies include non-human primate models, small animal studies, and support for vaccine development and infectious disease research—areas directly aligned with NIAID's research priorities. The SVEU program itself focuses on evaluating vaccines and therapeutic candidates using non-human primate models, making facility maintenance and animal care critical components of NIAID's preclinical research infrastructure. This delivery order represents essential operational support for ongoing vaccine evaluation studies that advance the agency's mission to combat infectious diseases.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Simian Vaccine Evaluation Units (SVEUs) | NIAID-DAIDS-NIHAI201800011 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/1 | 10/9/18, 10:51 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Exercise an Option | $214.2k | 3/25/26 | |
| P00007 | Change Order | $3.5k | 1/27/26 | |
| P00006 | Funding Only Action | ($473) | 6/25/25 | |
| P00005 | Exercise an Option | $209.6k | 3/13/25 | |
| P00004 | Exercise an Option | $204.9k | 3/20/24 |